• Hepatocarcinoma and cholangiocarcinoma: new treatment for liver tumors
• Colangiocarcinoma: medical therapies available and in progress
• Advanced hepatocarcinoma: positive results from the Cabozantinib study, in which Humanitas also took part
• EASL 2018: The Role of the Medical Oncologist in the Multidisciplinary Management of Hepatic carcinoma, Dr. Rimassa’s Report
• Hepatocarcinoma: the results of the Humanitas study published in The Lancet Oncology
• ASCO 2017: Humanitas Participates to the Congress with an Oral Presentation About Hepatocellular Carcinoma